Any More Athenas Out There? Plaintiffs May Allege So In Expected Suits
This article was originally published in The Rose Sheet
Executive Summary
Firms marketing cosmetics with drug-like properties could be targeted increasingly by suits requiring courts, and even juries, to interpret their regulatory status if the Supreme Court's decision not to hear Athena Cosmetics v. Allergan is seen as an invitation by consumers and the plaintiffs' bar.